Zobrazeno 1 - 10
of 67
pro vyhledávání: ''
Autor:
Alla Berlin, Leora Brazg Ferro, Ester Osher, Orit Gutfeld, Inbal Golomb, Inna Ospovat, Viacheslav Soyfer, Ido Wolf, Shira Peleg Hasson
Publikováno v:
Oncology. 99:373-379
Introduction: Extrapulmonary small-cell cancer (EPSCC) is a relatively rare malignancy. The management of EPSCC is usually extrapolated from small-cell lung cancer (SCLC). In spite of the morphological similarity of the 2 malignancies, there are many
Autor:
Diana Pettinato, Alfredo Mirandola, Francesca Zanellini, Amelia Barcellini, Marianna Roccio, Francesca Valvo, Ester Orlandi, Angiolo Gadducci, Concetta Laliscia
Publikováno v:
Oncology. 99:65-71
Background and Summary: The management of endometrial cancer, in an ever-older population with considerable comorbidity, remains a challenge for gynecological and radiation oncologists. Key Message: The present paper reviews literature data on treatm
Autor:
Masahiro Noda, Takaaki Arigami, Hiroshi Kurahara, Daisuke Matsushita, Satoshi Iino, Keishi Okubo, Yoshiaki Kita, Yoshikazu Uenosono, Yota Kawasaki, Shigehiro Yanagita, Sumiya Ishigami, Kosei Maemura, Shinichiro Mori, Ken Sasaki, Shoji Natsugoe
Publikováno v:
Oncology. 98:273-279
Objective: Chemotherapy is generally recommended as the first-line standard treatment in patients with liver metastasis from gastric cancer. However, the clinical impact of surgical treatment remains unclear in responders after chemotherapy. The pres
Autor:
Kausar Suleman, Noha Jastaniyah, Tusneem Elhassan, Wafa Alkhayal, Osama Almalik, Ali Hassan Mushtaq, Adher Al-Sayed, Dahish Ajarim, Emaan Haque, Taher Al-Tweigeri, Ahmed Badran
Publikováno v:
Oncology. 98:168-173
Background:There is a paucity of literature examining the impact of timing of surgery after neoadjuvant chemotherapy. Objective:This study aimed to analyze the impact of the time taken to initiate surgical treatment following completion of neoadjuvan
Autor:
Hiroshi Shibata, Takashi Kumada, Kazuto Tajiri, Michitaka Imai, Masashi Hirooka, Atsushi Hiraoka, Norio Itokawa, Kunihiko Tsuji, Taeang Arai, Masatoshi Kudo, Kojiro Michitaka, Kazuya Kariyama, Shinya Fukunishi, Korenobu Hayama, Shinichiro Nakamura, Ei Itobayashi, Toru Ishikawa, Hironori Ochi, Yoichi Hiasa, Hideko Ohama, Akemi Tsutsui, Toshifumi Tada, Koichi Takaguchi, Masanori Atsukawa, Kazuhito Kawata, Noritomo Shimada, Hidenori Toyoda
Publikováno v:
Oncology. 98:295-302
Background/Aim: Few studies have examined the details of nutritional status in patients with unresectable hepatocellular carcinoma (u-HCC) undergoing systemic chemotherapy with lenvatinib. We evaluated the prognostic/predictive value of nutritional s
Autor:
Yoshikazu Uenosono, Daisuke Matsushita, Yoshiaki Kita, Shigehiro Yanagita, Shoji Natsugoe, Hiroshi Kurahara, Masahiro Noda, Ken Sasaki, Sumiya Ishigami, Keishi Okubo, Takaaki Arigami, Takao Ohtsuka, Shinichiro Mori
Publikováno v:
Oncology. 98:798-806
Objective: Although chemotherapy has been clinically recommended as the initial treatment for patients with peritoneal dissemination of gastric cancer, poor prognosis has been noted among the same patients. However, the prognostic significance of con
Autor:
Chia Che Wu, Meng Che Hsieh, Cheng-Hua Huang, Shih Yu Huang, Harvey Yu-Li Su, Po Hui Chiang, Chun-Chieh Huang, Kun Ming Rau, Jui Ming Liu, Hao Lun Luo, Ming Tse Sung
Publikováno v:
Oncology. 98:146-153
Objectives: Platinum-based chemotherapy is the standard treatment for metastatic urothelial carcinoma (mUC). However, considering elderly patients often experience comorbidities and frailty, the utility of cisplatin-based chemotherapy for elderly pat
Autor:
Takamichi Komori, Masaaki Motoori, Kazumasa Fujitani, Susumu Miyazaki, Yasuhiro Miyazaki, Norihiro Matsuura, Hisateru Komatsu, Kazuhiro Iwase, Yujiro Nishizawa, Akira Tomokuni
Publikováno v:
Oncology. 98:29-34
Purpose: Neoadjuvant chemotherapy (NAC) followed by surgery is a promising treatment strategy for patients with advanced gastric cancer. Severe toxicity associated with the treatment may reduce the dose intensity of chemotherapy, resulting in the eff
Autor:
Francesca Platini, Alba Bianco, Carlo Resteghini, Donata Galbiati, Massimo Milione, Cristiana Bergamini, Paolo Bossi, Lisa Licitra, Salvatore Alfieri, Stefano Cavalieri, Federica Perrone, Laura D. Locati
Publikováno v:
Oncology. 97:112-118
Background: Recurrent or metastatic (R/M) skin squamous cell carcinoma (sSCC) not amenable of surgery or irradiation may benefit from systemic therapies. Epidermal growth factor receptor (EGFR) inhibitors and, more recently, immune checkpoint blocker
Autor:
Kenichi Yoshimura, Mitsunori Morita, Naoyuki Sone, Yoshinori Hasegawa, Chikara Sakaguchi, Toshihiko Kaneda, Tetsuo Noguchi, Takashi Niwa, Hiroshige Yoshioka, Masataka Hirabayashi, Toyohiro Hirai, Toshihide Yokoyama, Satoshi Ikeda, Yasutaka Nakano, Chihito Komaki, Tadashi Ishida, Hiromi Tomioka
Publikováno v:
Oncology. 97:327-333
Background: There has been no study so far on gemcitabine continuous maintenance therapy targeting only squamous non-small-cell lung cancer (NSCLC) patients. This study aimed to assess the efficacy and safety of cisplatin plus gemcitabine followed by